Literature DB >> 27503577

Melatonin decreases brain apoptosis, oxidative stress, and CD200 expression and increased survival rate in mice infected by Venezuelan equine encephalitis virus.

Milagros Montiel1, Ernesto Bonilla2, Nereida Valero3, Jesús Mosquera2, Luz M Espina2, Yasmir Quiroz4, Melchor Álvarez-Mon5.   

Abstract

BACKGROUND: Pro-inflammatory and oxidative events during brain Venezuelan equine encephalitis virus infection could lead to apoptosis and induce anti-inflammatory responses (increased expression of CD200). The aim of this study was to determine the effect of melatonin on brain apoptosis, oxidative stress, and CD200 molecule in mice and neuroblastoma cultures infected by Venezuelan equine encephalitis virus.
METHODS: Mice were infected with 10 median lethal doses (LD50) of Venezuelan equine encephalitis virus, treated with melatonin (500 µg/kg bw; three days before infection and during all experimental time) and sacrificed on days 1, 3, and 5 postinfection. Brain samples were obtained at those periods of time. In addition, infected neuroblastoma cell cultures (multiplicity of infection [MOI]: 1) were treated with 0, 0.1, 0.5, and 1 mM of melatonin and analyzed at 2, 4, and 6 h. CD200 and apoptosis expressions were analyzed by immunohistochemistry and TUNEL assay, respectively. Nitrites and malondialdehyde were determined by appropriate biochemical methods.
RESULTS: Increased brain expression of apoptosis, nitrite, and malondialdehyde productions and CD200 of infected mice were found. Melatonin diminished those expressions. Similarly, high apoptosis expression and nitrite and malondialdehyde productions on infected neuroblastoma cultures were diminished by melatonin. Melatonin increased the survival rate (25%) in Venezuelan equine encephalitis virus-infected animals compared with untreated infected mice (0%).
CONCLUSIONS: Neurological damage during brain Venezuelan equine encephalitis virus infection could be mediated by apoptosis and oxidative stress and CD200 molecule could be an important anti-inflammatory response. Melatonin could be beneficial reducing apoptosis and oxidative stress.
© The Author(s) 2016.

Entities:  

Keywords:  CD200; Venezuela equine encephalitis virus; apoptosis; brain; neuroblastoma; survival rate

Mesh:

Substances:

Year:  2016        PMID: 27503577      PMCID: PMC5890526          DOI: 10.1177/2040206616660851

Source DB:  PubMed          Journal:  Antivir Chem Chemother        ISSN: 0956-3202


  35 in total

1.  Oxidative stress and apoptosis.

Authors: 
Journal:  Pathophysiology       Date:  2000-09

2.  [Encephalitis, Venezuelan Equine, 30 years of study in Venezuela, 1963-1993].

Authors: 
Journal:  Invest Clin       Date:  1995-11       Impact factor: 0.683

3.  Melatonin protects mice infected with Venezuelan equine encephalomyelitis virus.

Authors:  E Bonilla; N Valero-Fuenmayor; H Pons; L Chacín-Bonilla
Journal:  Cell Mol Life Sci       Date:  1997-05       Impact factor: 9.261

4.  [Importance of transmission electron microscopy in the diagnosis of a Venezuelan equine encephalitis outbreak in 1995 in the Venezuelan Guajira].

Authors:  N Valero-Fuenmayor; J García-Tamayo; S Escorihuela-García; E Caleiras; D Parada
Journal:  Invest Clin       Date:  1997-06       Impact factor: 0.683

5.  Immunopathogenesis and immune modulation of Venezuelan equine encephalitis virus-induced disease in the mouse.

Authors:  P C Charles; J Trgovcich; N L Davis; R E Johnston
Journal:  Virology       Date:  2001-06-05       Impact factor: 3.616

6.  Regulation of the expression of death receptors and their ligands by melatonin in haematological cancer cell lines and in leukaemia cells from patients.

Authors:  Sara Casado-Zapico; Vanesa Martín; Guillermo García-Santos; Jezabel Rodríguez-Blanco; Ana M Sánchez-Sánchez; Elisa Luño; Carlos Suárez; Juana M García-Pedrero; Sofía T Menendez; Isaac Antolín; Carmen Rodriguez
Journal:  J Pineal Res       Date:  2011-02-24       Impact factor: 13.007

7.  Systemic and local anti-C5 therapy reduces the disease severity in experimental autoimmune uveoretinitis.

Authors:  D A Copland; K Hussain; S Baalasubramanian; T R Hughes; B P Morgan; H Xu; A D Dick; L B Nicholson
Journal:  Clin Exp Immunol       Date:  2009-12-04       Impact factor: 4.330

8.  Melatonin induces changes to serum cytokines in mice infected with the Venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Ernesto Bonilla; Héctor Pons; Leonor Chacin-Bonilla; Florencio Añez; Luz Marina Espina; Shirley Medina-Leendertz; Jorge García Tamayo
Journal:  Trans R Soc Trop Med Hyg       Date:  2002 May-Jun       Impact factor: 2.184

Review 9.  Venezuelan equine encephalitis.

Authors:  Scott C Weaver; Cristina Ferro; Roberto Barrera; Jorge Boshell; Juan-Carlos Navarro
Journal:  Annu Rev Entomol       Date:  2004       Impact factor: 19.686

10.  Melatonin decreases nitric oxide production and lipid peroxidation and increases interleukin-1 beta in the brain of mice infected by the Venezuelan equine encephalomyelitis virus.

Authors:  Nereida Valero; Luz MarinaEspina; Ernesto Bonilla; Jesus Mosquera
Journal:  J Pineal Res       Date:  2007-03       Impact factor: 13.007

View more
  11 in total

Review 1.  Melatonin: Regulation of Viral Phase Separation and Epitranscriptomics in Post-Acute Sequelae of COVID-19.

Authors:  Doris Loh; Russel J Reiter
Journal:  Int J Mol Sci       Date:  2022-07-23       Impact factor: 6.208

Review 2.  A Review of the Potential Effects of Melatonin in Compromised Mitochondrial Redox Activities in Elderly Patients With COVID-19.

Authors:  Wen-Lin Su; Chia-Chao Wu; Shu-Fang Vivienne Wu; Mei-Chen Lee; Min-Tser Liao; Kuo-Cheng Lu; Chien-Lin Lu
Journal:  Front Nutr       Date:  2022-06-20

Review 3.  Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin?

Authors:  Alejandro Romero; Eva Ramos; Francisco López-Muñoz; Emilio Gil-Martín; Germaine Escames; Russel J Reiter
Journal:  Cell Mol Neurobiol       Date:  2020-08-09       Impact factor: 4.231

4.  Pineal hormone melatonin as an adjuvant treatment for COVID‑19 (Review).

Authors:  Marilena Vlachou; Angeliki Siamidi; Aikaterini Dedeloudi; Sofia K Konstantinidou; Ioannis P Papanastasiou
Journal:  Int J Mol Med       Date:  2021-02-12       Impact factor: 4.101

Review 5.  Role of Melatonin on Virus-Induced Neuropathogenesis-A Concomitant Therapeutic Strategy to Understand SARS-CoV-2 Infection.

Authors:  Prapimpun Wongchitrat; Mayuri Shukla; Ramaswamy Sharma; Piyarat Govitrapong; Russel J Reiter
Journal:  Antioxidants (Basel)       Date:  2021-01-02

Review 6.  SARS-CoV-2 and other coronaviruses negatively influence mitochondrial quality control: beneficial effects of melatonin.

Authors:  Saeed Mehrzadi; Mohammad Yahya Karimi; Alireza Fatemi; Russel J Reiter; Azam Hosseinzadeh
Journal:  Pharmacol Ther       Date:  2021-03-01       Impact factor: 13.400

Review 7.  Melatonin in Early Treatment for COVID-19: A Narrative Review of Current Evidence and Possible Efficacy.

Authors:  Kristina M Cross; Dylan M Landis; Laveena Sehgal; J Drew Payne
Journal:  Endocr Pract       Date:  2021-06-10       Impact factor: 3.443

8.  Screening of melatonin, α-tocopherol, folic acid, acetyl-L-carnitine and resveratrol for anti-dengue 2 virus activity.

Authors:  Atchara Paemanee; Atitaya Hitakarun; Sittiruk Roytrakul; Duncan R Smith
Journal:  BMC Res Notes       Date:  2018-05-16

9.  CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease.

Authors:  Andrea Comella Bolla; Tony Valente; Andres Miguez; Veronica Brito; Silvia Gines; Carme Solà; Marco Straccia; Josep M Canals
Journal:  PLoS One       Date:  2019-12-02       Impact factor: 3.240

Review 10.  Pharmacological agents under investigation in the treatment of coronavirus disease 2019 and the importance of melatonin.

Authors:  Hakan Parlakpinar; Seyhan Polat; Haci Ahmet Acet
Journal:  Fundam Clin Pharmacol       Date:  2020-10-14       Impact factor: 2.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.